1.Michael, KD, Crowley, SL.How effective are treatments for child and adolescent depression? A meta-analytic review. Clin Psychol Rev 2002;22:247–269.
2.Papanikolaou, K, Richardson, C, Pehlivanidis, A, Papadopoulou-Daifoti, Z.Efficacy of antidepressants in child and adolescent depression: a meta-analytic study. J Neural Transm 2006;113:399–415.
3.Reinblatt, SP, Riddle, MA.The pharmacological management of childhood anxiety disorders: a review. Psychopharmacology 2007;191:67–86.
4.Tsapakis, EM, Soldani, F, Tondo, L, Baldessarini, RJ.Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008;193:10–17.
5.Masi, G, Liboni, F, Brovedani, P.Pharmacotherapy of major depressive disorder in adolescents. Expert Opin Pharmacother 2010;11:375–386.
6.Gentile, S.Antidepressant use in children and adolescents diagnosed with major depressive disorder: what can we learn from published data? Rev Recent Clin Trials 2010;5:63–75.
7.Connolly, SD, Bernstein, GA.Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007;46:267–283.
8.Birmaher, B, Brent, D, Bernet, W et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503–1526.
9.NICE. Depression in Children and Young People. Identification and Management in Primary, Community and Secondary Care. 2005. URL http://www.nice.org.uk [accessed on April 2011].
10.Baldwin, DS, Anderson, IM, Nutt, DJ et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005;19:567–596.
11.Thorpe, L, Whitney, DK, Kutcher, SP, Kennedy, SH.Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatry 2001;46(Suppl. 1):63S–76S.
12.Tandon, M, Pruett, JRAn overview of the use of antidepressants in children and adolescents. Mo Med 2008;105:79–84.
13.van Engeland, H.Pharmacotherapy and behaviour therapy–competition or cooperation? Acta Paedopsychiatr 1993;56:123–127.
14.March, J, Silva, S, Petrycki, S et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807–820.
15.Brent, D, Emslie, G, Clarke, G et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008;299:901–913.
16.Goodyer, I, Dubicka, B, Wilkinson, P et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ 2007; 335:142.
17.Clarke, G, Debar, L, Lynch, F et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry 2005;44:888–898.
18.Walkup, JT, Albano, AM, Piacentini, J et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:2753–2766.
19.Dubicka, B, Elvins, R, Roberts, C, Chick, G, Wilkinson, P, Goodyer, IM.Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010;197:433–440.
20.Jadad, AR, Moore, RA, Carroll, D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.
21.Egger, M, Smith, GD, Phillips, AN.Meta-analysis: Principles and procedures. BMJ 1997;315:1533–1537.
22.Molenaar, PJ, Dekker, J, Van, R, Hendriksen, M, Vink, A, Schoevers, RA.Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression? Depress Anxiety 2007;24:553–562.
23.Sharp, DM, Power, KG, Simpson, RJ, Swanson, V, Anstee, JA.Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care. Br J Gen Pract 1997;47:150–155.
24.Curry, J, Rohde, P, Simons, A et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1427–1439.
25.Asarnow, JR, Emslie, G, Clarke, G et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009;48:330–339.
26.March, JS, Silva, S, Petrycki, S et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:1132–1143.